[{"NetIncomeLoss_3_Q3_USD":-141534000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":40185000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":17353000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":30250127.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":30367727.0,"AccountsAndOtherReceivablesNetCurrent_0_Q3_USD":400000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":43847000.0,"DerivativeLiabilitiesCurrent_0_Q3_USD":847000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-6000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-59476000.0,"PaymentsToAcquireInvestments_3_Q3_USD":179055000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-6000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":925000.0,"AssetsCurrent_0_Q3_USD":196805000.0,"OperatingLeaseExpense_3_Q3_USD":500000.0,"OperatingLeaseExpense_1_Q3_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7354161.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":345000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":916000.0,"CommonStockSharesIssued_0_Q3_shares":30562167.0,"Assets_0_Q3_USD":235167000.0,"ShareBasedCompensation_3_Q3_USD":17523000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1664000.0,"OperatingLeaseLiability_0_Q3_USD":2778000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":1363000.0,"Liabilities_0_Q3_USD":178771000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":371104000.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_1_Q3_USD":-1355000.0,"ShortTermInvestments_0_Q3_USD":134190000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":219000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3178000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":117600000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-83000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":7000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-565000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-35000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":25000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":9000.0,"CommonStockValue_0_Q3_USD":3000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9429216.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":14997000.0,"PaymentOfFinancingAndStockIssuanceCosts_3_Q3_USD":null,"DepreciationDepletionAndAmortization_3_Q3_USD":253000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":103653000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":30471000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":72851000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q3_USD":134190000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost_3_Q3_USD":600000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-141623000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-47101000.0,"OtherAssetsNoncurrent_0_Q3_USD":1641000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":55844000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2088000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":400000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-314705000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-86242000.0,"CommonStockSharesOutstanding_0_Q3_shares":30406303.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_3_Q3_USD":417000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-141509000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-47099000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7415000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-99611000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":888000.0,"LiabilitiesCurrent_0_Q3_USD":50387000.0,"AccountsPayableCurrent_0_Q3_USD":5003000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6371000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":80000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-6000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":19000000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.08,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":374000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":55844000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"OperatingLeasePayments_3_Q3_USD":645000.0,"HeldToMaturitySecuritiesFairValue_0_Q3_USD":149187000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_Q3_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1060000.0,"NetIncomeLoss_1_Q3_USD":-47108000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":52509000.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_3_Q3_USD":-417000.0,"LongTermInvestments_0_Q3_USD":14997000.0,"StockholdersEquity_0_Q3_USD":56396000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":230000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2241000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":16000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5000000.0,"OperatingIncomeLoss_3_Q3_USD":-127838000.0,"OperatingIncomeLoss_1_Q3_USD":-42824000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":134190000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":6914000.0,"InvestmentIncomeInterest_3_Q3_USD":301000.0,"InvestmentIncomeInterest_1_Q3_USD":72000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":21000.0,"PreferredStockValue_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6715000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17523000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7415000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q3_USD":7000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":690000.0,"OperatingExpenses_3_Q3_USD":143838000.0,"OperatingExpenses_1_Q3_USD":47824000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-4.68,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.55,"ProfitLoss_3_Q3_USD":-141534000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":19000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":235167000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":4462000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]